Stephen T. Bello
P.R. China
Sar, China
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Cholecystokinin modulates age-dependent thalamocortical neuroplasticity.
Journal: eLife
Published: November 20, 2025
Role of Neuronal Cholecystokinin Receptor: An Emerging Therapeutic Target for Ameliorating Neurological Diseases.
Journal: Molecular neurobiology
Published: August 13, 2025
A cholecystokinin 2 receptor antagonist alleviates seizure severity in a mouse and miniature pig model of temporal lobe epilepsy.
Journal: Epilepsy & behavior : E&B
Published: May 15, 2025
New frontier for epilepsy treatment through targeting cellular senescence.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: March 03, 2025
Cholecystokinin facilitates the formation of long-term heterosynaptic plasticity in the distal subiculum.
Journal: Communications biology
Published: August 12, 2024
Spatiotemporal analysis of regional and age differences in tuberculosis prevalence in mainland China.
Journal: Tropical medicine & international health : TM & IH
Published: July 24, 2024
Neuropeptide cholecystokinin: a key neuromodulator for hippocampal functions.
Journal: Neural regeneration research
Published: April 26, 2024
Targeting NMDA receptors with an antagonist is a promising therapeutic strategy for treating neurological disorders.
Journal: Behavioural brain research
Published: April 25, 2024
Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action.
Journal: Frontiers in pharmacology
Published: March 19, 2024
Protocol for induction of heterosynaptic long-term potentiation in the mouse hippocampus via dual-opsin stimulation technique.
Journal: STAR protocols
Published: December 07, 2023
Last Updated: 09/26/2026